This content is machine translated Lung Cancer An evaluation of current diagnostic and therapeutic strategies. This issue of InFo ONKOLOGIE & HÄMATOLOGIE is about lung cancer. In view of the high prevalence – in men it is still the most common malignancy of all –…
View Post 3 min This content is machine translated QualiCCare New standards in the treatment and care of COPD patients Once again, there were many interesting presentations to be heard at this year’s Trend Days Health in Lucerne. It was all about benchmarking in healthcare: useful, not useful? And what…
View Post 4 min This content is machine translated Phytotherapy for asthma and COPD Clinical studies show mixed results In various folk medicine traditions such as TCM, Ayurvedic or Indian medicine, there are a number of herbal preparations for asthma and COPD, but they have often not been verified…
View Post 4 min This content is machine translated Chronic rhinosinusitis Colorful mixture instead of independent disease? If a patient suffers from chronic inflammation of the mucous membranes in the nose and sinuses, it is important to look closely. Especially the polypous variant could be associated with…
View Post 6 min This content is machine translated COPD exacerbation Five days of prednisone 40 mg is enough Background: In Switzerland, about 5-7% of the population and certainly 28% of smokers suffer from COPD (“chronic obstructive pulmonary disease”). Acute exacerbation of COPD is a risk factor for further…
View Post 3 min This content is machine translated EPs 7630 against bronchitis A plant extract with high evidence Pelargonium sidoides, a plant native to southern Africa, has been studied by various research teams since the 1990s. Folk application against bronchitis gave the medical evidence, also a meta-analysis confirmed…
View Post 5 min This content is machine translated Follow-up of curatively operated NSCLC. Many questions are still open Lung cancer is the most common fatal cancer worldwide, and its incidence is still increasing in modern times. Despite advances in diagnosis and treatment, the lethality of lung cancer leads…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
View Post 6 min This content is machine translated Suspicion of lung carcinoma Silent preclinical lung findings complicate diagnosis Lung carcinoma usually presents to the general practitioner as advanced disease with mostly nonspecific symptoms: As a silent preclinical lung finding, it must be specifically sought. Knowledge of the clinical…
View Post 2 min This content is machine translated Bronchus carcinoma Dawn in non-small cell lung cancer? At the beginning of every medical advance is the intention and hope of the researcher to understand a problem in order to then bring it to a solution. Hope is…
View Post 1 min This content is machine translated Interview Interview with Prof. Dr. med. Nils Kucher, Bern, Head of the ULTIMA Study Interview with Prof. Dr. Kucher.
